Legacy Topic: Health Care
OxyContin's waiting game: Generic drug makers salivate while the FDA wants safer pills
Apr 16, 2013
OxyContin is supposed to come off patent and generic drug makers are excited. But, the FDA may put a stop to it all to wait for safer pills.
DNA sequencing celebrates its first decade
Apr 12, 2013
The anniversary brings with it a new and lucrative era of personalized medicine.
Genetics may be the next big thing in medicine, but at what cost?
Apr 12, 2013
Many believe genetics are the next big thing in medicine, but one question for this new era of personalized medicine is cost.
Biogen Idec CEO on drug costs and taking on multiple sclerosis
Apr 11, 2013
Biogen Idec CEO George Scangos discusses his company's new multiple sclerosis drug, pricing strategy, and research process.
When can you join a health insurance exchange? Few know.
Apr 4, 2013
A new study says only a fraction of people know they can sign up in October for the insurance exchanges that are key to President Obama's health care overhaul.
Dementia is highest cost disease and rising
Apr 4, 2013
A report in the latest issue of the New England Journal of Medicine says the U.S. spends more on treating dementia than any other disease including cancer and heart disease.
Rural doctors slow to adopt electronic medical records
Apr 3, 2013
The federal government wants every doctor to have electronic records by 2015. But the high cost prevents some rural physicians from moving away from paper records.
For public good, not for profit.
Nursing exams keep pace with health care tech advances
by
Molly Wood
Apr 2, 2013
It helps to be up on the latest tech if you want to be a registered nurse. This week the National Council of State Boards of Nursing is rolling out a new update to its nurse licensing exam.
India Novartis patent ruling: Good for access, bad for innovation?
Apr 1, 2013
India's Supreme Court has rejected a patent filed by Swiss drug maker Novartis for its cancer drug. The decision has implications for the pharmaceutical industry and millions of people in poor countries.
India rejects Novartis cancer drug patent
Apr 1, 2013
The Supreme Court in India has rejected an attempt by the Swiss drug maker Novartis to patent an update to a cancer treatment.